CanCOLD is funded through the CIHR/Rx&D Collaborative Research Program (IRO-93326), in partnership with a consortium from the industry, i.e., AstraZeneca, Boehringer Ingelheim, GlaxoSmithKlin and Pfizer, and the Respiratory Health Network of the FRSQ.

Home | Contact us | Français

Financial Partners

CanCOLD is funded through the CIHR/Rx&D Collaborative Research Program (IRO-93326),
in partnership with a consortium from the industry, i.e., AstraZeneca, Boehringer Ingelheim,
GlaxoSmithKlin and Pfizer, and the Respiratory Health Network of the FRSQ.

PUBLIC FUNDING

INDUSTRY FUNDING